What you don’t expect when you’re expecting: How genetic testing can provide insights that empower reproductive possibility By Cary Davies 28 February 2025 Next Biosciences is a leading South African biotech company, that offers additional support for each step along the unpredictable path to parenthood.
The Science of Self: Why Genetic Testing should be on your priority list. By Cary Davies 10 December 2024 We are living in the age of information, where consumer access to scientific and statistical data is readily available to guide our judgement in all areas of life.
NIPT Cumulative Prenatal Testing Statistic 2024 By Next Biosciences 19 March 2024 Non-Invasice Prenatal Testing (NIPT) was introduced into clinical practice as a screening test for the most common chromosome abnormalities in 2011 and has since revolutionised prenatal care. Due to its high sensitivity and specificity, NIPT is recommended as a first-tier screening test for all pregnancies by many international societies including American College of Obstetricians and Gynecologists (ACOG) and the International Society for Prenatal Diagnosis (ISPD).
10 weeks pregnant, 30 to go: Pregnancy insights that you should know By Cary Davies 14 March 2024 You are well on your way now and excitement will be setting in. At 10 weeks, the embryo can officially be called a fetus and your doctor or midwife will be comfortable revealing your due date. As the exciting reality of your pregnancy sinks in, there is much to learn and so much to plan.
Kelly Loggenberg takes the mic on the renowned DNA Today podcast channel By Next Biosciences 15 February 2024 In a thought-provoking conversation with host Kira Dineen, Kelly delved into the world of embryo (PGT - Preimplantation Genetic Testing) and miscarriage (POCScreen - Products of Conception Screening) genetic testing and offered a unique perspective that resonated with listeners around the globe.
Unlocking possibilities with advanced genetic testing By Ashleigh Bouguenon 15 February 2024 This month reminds us of the journey leading to successful and healthy pregnancies, especially for those navigating the sometimes-emotional path of IVF and pregnancy loss.
Next Biosciences is just here for the sex with MiniMi By Next Biosciences 4 December 2023 Next Biosciences' Laboratory Research and Technical Specialist, Gloudi Agenbag has developed the MiniMi Early Fetal Sex Test that allows expecting parents the choice to find out their baby’s sex from as early as 10 weeks, with an accuracy of 98%.
Updated position statement from the ISPD By Next Biosciences 13 November 2023 The International Society for Prenatal Diagnosis have recently published a position statement in Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies.
Newborn Screening: Genetic and metabolic disease diagnoses in South Africa By Next Biosciences 21 September 2023 In this blog post, we will delve into the landscape of genetic and metabolic disease diagnoses in South Africa, highlighting key conditions, prevalence rates, and the role of ethnicity in susceptibility.
Importance of a universal newborn screening in South Africa By Next Biosciences 18 August 2023 Newborn screening is a remarkable tool that empowers healthcare professionals to identify potential threats before they can impact a new baby’s health.